166 related articles for article (PubMed ID: 36905129)
1. Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
Shukuya T; Takahashi K; Shintani Y; Miura K; Sekine I; Takayama K; Inoue A; Okamoto I; Kiura K; Kawaguchi T; Yamamoto N; Miyaoka E; Yoshino I; Date H
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1274-1285. PubMed ID: 36905129
[TBL] [Abstract][Full Text] [Related]
2. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
4. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
5. An analysis of the relationship between metastases and cachexia in lung cancer patients.
Shiono M; Huang K; Downey RJ; Consul N; Villanueva N; Beck K; Fenn K; Dietz D; Yamaguchi T; Kato S; Divgi C; Kalinsky K; Wei Y; Zhang Y; Borczuk AC; Inoue A; Halmos B; Acharyya S
Cancer Med; 2016 Sep; 5(9):2641-8. PubMed ID: 27485414
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of the cachexia index in patients with small cell lung cancer.
Go SI; Park MJ; Lee GW
BMC Cancer; 2021 May; 21(1):563. PubMed ID: 34001060
[TBL] [Abstract][Full Text] [Related]
7. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
[TBL] [Abstract][Full Text] [Related]
8. Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
Le-Rademacher J; Lopez C; Wolfe E; Foster NR; Mandrekar SJ; Wang X; Kumar R; Adjei A; Jatoi A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1501-1508. PubMed ID: 32940014
[TBL] [Abstract][Full Text] [Related]
9. Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.
Mytelka DS; Li L; Benoit K
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):86-92. PubMed ID: 29205930
[TBL] [Abstract][Full Text] [Related]
10. Anamorelin in Japanese patients with cancer cachexia: an update.
Wakabayashi H; Arai H; Inui A
Curr Opin Support Palliat Care; 2023 Sep; 17(3):162-167. PubMed ID: 37389636
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.
Inoue A; Yoshida K; Morita S; Imamura F; Seto T; Okamoto I; Nakagawa K; Yamamoto N; Muto S; Fukuoka M
Jpn J Clin Oncol; 2016 May; 46(5):462-7. PubMed ID: 26977054
[TBL] [Abstract][Full Text] [Related]
13. Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.
Sakaguchi T; Maeda K; Takeuchi T; Mizuno A; Kato R; Ishida Y; Ueshima J; Shimizu A; Amano K; Mori N
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):370-379. PubMed ID: 38115133
[TBL] [Abstract][Full Text] [Related]
14. Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung Cancer.
Alvarez CM; Aliru M; Gannavarapu BS; Song T; Gilmore LA; Olaechea S; Gomez DR; Ahn C; Infante RE; Iyengar P
Am J Clin Oncol; 2024 Feb; 47(2):49-55. PubMed ID: 38011024
[TBL] [Abstract][Full Text] [Related]
15. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks.
van der Meij BS; Schoonbeek CP; Smit EF; Muscaritoli M; van Leeuwen PA; Langius JA
Br J Nutr; 2013 Jun; 109(12):2231-9. PubMed ID: 23153477
[TBL] [Abstract][Full Text] [Related]
16. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
[TBL] [Abstract][Full Text] [Related]
18. [Cachexia and Sarcopenia Associated with Lung Cancer].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1537-1541. PubMed ID: 33268723
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).
Blum D; Stene GB; Solheim TS; Fayers P; Hjermstad MJ; Baracos VE; Fearon K; Strasser F; Kaasa S;
Ann Oncol; 2014 Aug; 25(8):1635-42. PubMed ID: 24562443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
